Diabetic Medicine

Diabetic Medicine Journal

Publication venue for

Hypoglycaemia is reduced with use of inhaled Technosphere (R) Insulin relative to insulin aspart in type 1 diabetes mellitus. 37:752-759. 2020
Hypoglycaemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus 2019
A novel combination of insulin degludec and liraglutide, IDegLira, enables patients with Type 2 diabetes to reach target glycaemic control faster than its individual components alone. 32:75-76. 2015
Greater postprandial glucose control across all three daily meals with liraglutide compared with placebo when added to metformin and rosiglitazone in patients with Type 2 diabetes: posthoc analysis of Liraglutide Effect and Action on Diabetes (LEAD)4. 31:177-177. 2014
Liraglutide achieves HbA1c targets more often than sitagliptin or exenatide when added to metformin in patients with Type 2 diabetes and a baseline HbA1c < 8.0%. 30:57-57. 2013
The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera (R) as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial. 25:662-670. 2008

International Standard Serial Number (ISSN)

0742-3071